These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 6713900)

  • 41. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aluminum metabolism and toxicity in renal failure: a review.
    Mayor GH; Lohr TO; Sanchez TV
    J Environ Pathol Toxicol Oncol; 1985; 6(1):43-50. PubMed ID: 3906081
    [No Abstract]   [Full Text] [Related]  

  • 43. Dialysis encephalopathy: recovery after interruption of aluminium intake.
    Poisson M; Mashaly R; Lebkiri B
    Br Med J; 1978 Dec; 2(6152):1610-1. PubMed ID: 728750
    [No Abstract]   [Full Text] [Related]  

  • 44. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V; Petrov I; Antonov S; Kiriakov Z
    Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive dialysis encephalopathy from dialysate aluminum.
    Rozas VV; Port FK; Rutt WM
    Arch Intern Med; 1978 Sep; 138(9):1375-7. PubMed ID: 686928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In end-stage renal failure, does infection lead to elevated plasma aluminium and neurotoxicity? Implications for monitoring.
    Fenwick S; Roberts EA; Mahesh BS; Roberts NB
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):149-52. PubMed ID: 15829127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aluminum metabolism.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S8-11. PubMed ID: 3458002
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW; Stewart Wk; Fell GS; Halls DJ
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fracture osteomalacia, CAPD, and aluminium.
    Kingswood C; Banks RA; Bunker T; Harrison P; Mackenzie C
    Lancet; 1983 Jan; 1(8314-5):70-1. PubMed ID: 6129404
    [No Abstract]   [Full Text] [Related]  

  • 50. [Aluminum-induced osteomalacia in chronic hemodialysis].
    Smetana S; Popovtzer MM; Bar-Khayim Y
    Harefuah; 1987 Jun; 112(12):595-7. PubMed ID: 3428727
    [No Abstract]   [Full Text] [Related]  

  • 51. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
    Espinoza O; Gehrung E; Roessler E; Katz E; Pérez A; Delmastro J
    Rev Med Chil; 1986 Sep; 114(9):867-71. PubMed ID: 3575972
    [No Abstract]   [Full Text] [Related]  

  • 52. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)].
    Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P
    Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aluminum related dialysis osteomalacia and dementia after prolonged use of the Redy cartridge.
    Pierides AM; Frohnert PP
    Trans Am Soc Artif Intern Organs; 1981; 27():629-33. PubMed ID: 7331145
    [No Abstract]   [Full Text] [Related]  

  • 54. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.
    Netter P; Kessler M; Burnel D; Hutin MF; Delones S; Benoit J; Gaucher A
    J Rheumatol; 1984 Feb; 11(1):66-70. PubMed ID: 6699835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recognition and management of aluminum intoxication in children.
    Tsuru N; Williams JL; Chan JC
    Int J Pediatr Nephrol; 1987; 8(3):177-86. PubMed ID: 3323095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dialysis dementia syndrome and aluminum intoxication.
    Sideman S; Manor D
    Nephron; 1982; 31(1):1-10. PubMed ID: 7110469
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of aluminum on bone and cell localization.
    Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
    Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
    [No Abstract]   [Full Text] [Related]  

  • 58. Aluminum toxicity in chronic renal failure.
    Jones B; Epstein M
    Clin Nephrol; 1990 May; 33(5):257. PubMed ID: 2354566
    [No Abstract]   [Full Text] [Related]  

  • 59. [The role of aluminum in the development of osteomalacia in patients on chronic hemodialysis].
    Adamiec R; Uzar J
    Pol Arch Med Wewn; 1988 Jan; 79(1):3-12. PubMed ID: 3275167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of hyperphosphatemia in chronic renal failure].
    Babarykin DA; Afanas'eva GA; Shul'man OM; Luse LIa; Rozental' RL
    Ter Arkh; 1984; 56(7):64-6. PubMed ID: 6484838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.